Ford Financial Group, LLC Eli Lilly & CO Transaction History

Ford Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$234.69 - $291.66 $105,610 - $131,247	-450 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $101,182 - $125,568	450 New	450 $124,000
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $104,152 - $128,173	-470 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $84,858 - $109,763	470 New	470 $107,000
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $9,869 - $11,650	-133 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $10,898 - $11,689	133	133 $11,000

4,009

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $788B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Ford Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ford Financial Group, LLC with notifications on news.